finasteride has been researched along with Intraepithelial Prostatic Neoplasia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abate-Shen, C; Barbieri, CE; Cremers, S; Dutta, A; Golombos, DM; Kim, JY; Liu, D; Mitrofanova, A; Mosquera, JM; Mostaghel, EA; Panja, S; Virk, RK; Zott, R | 1 |
| Soloway, M | 1 |
| Kim, J; Li, J | 1 |
| Damjanoski, I; Küfer, R; Müller, J; Rinnab, L; Schnöller, TJ | 1 |
| Cote, RJ; Ross, RK; Skinner, E | 1 |
| Bostwick, DG; Civantos, F; Montironi, R; Qian, J; Roehrborn, CG | 1 |
| Allory, Y; Cochand Priollet, B; de la Taille, A; Leroy, X; Molinié, V; Paraf, F; Ruffion, A | 1 |
| Asamoto, M; Cho, YM; Shirai, T; Suzuki, S; Takahashi, S; Tang, M | 1 |
| Coltman, CA; Darke, A; La Rosa, FG; Lippman, SM; Lucia, MS; Parnes, HL; Redman, MW; Thompson, IM | 1 |
| Bismarck, E; Dörsam, HJ; Fischer, C; Lümmen, G; Schmitz-Dräger, BJ | 1 |
| Bartels, PH; Diamanti, L; Hamilton, PW; Montironi, R; Pomante, R; Thompson, D | 1 |
| Cote, RJ; Henderson, BE; Mertes, SJ; Pike, MC; Ross, RK; Salem, CE; Skinner, EC; Stanczyk, FZ | 1 |
| Lieberman, R | 1 |
| Barnes, S; Brawley, OW; Parnes, H | 1 |
| Reid-Pitts, W | 1 |
5 review(s) available for finasteride and Intraepithelial Prostatic Neoplasia
| Article | Year |
|---|---|
Molecular profiles of finasteride effects on prostate carcinogenesis.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Androgens; Animals; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azasteroids; Dihydrotestosterone; Disease Progression; Dutasteride; Epithelial Cells; Finasteride; Humans; Isoenzymes; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Patient Selection; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Stromal Cells | 2009 |
Does finasteride alter the pathology of the prostate and cancer grading?
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Humans; Male; Neoplasm Staging; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2004 |
[Is tumour grade applicable to finasteride-treated prostate cancer?].
Topics: 5-alpha Reductase Inhibitors; Animals; Atrophy; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Neoplasm Staging; Prostate; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2005 |
Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemoprevention; Drug Design; Finasteride; Gene Expression Profiling; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2001 |
The future of prostate cancer prevention.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Anticarcinogenic Agents; Antioxidants; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diet; Double-Blind Method; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Selenium; Soybean Proteins; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E | 2001 |
2 trial(s) available for finasteride and Intraepithelial Prostatic Neoplasia
| Article | Year |
|---|---|
Finasteride decreases the risk of prostatic intraepithelial neoplasia.
Topics: Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2007 |
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
Topics: Adenocarcinoma; Aged; Biopsy; Cell Division; Enzyme Inhibitors; Epithelial Cells; Evaluation Studies as Topic; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 1998 |
8 other study(ies) available for finasteride and Intraepithelial Prostatic Neoplasia
| Article | Year |
|---|---|
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
Topics: 5-alpha Reductase Inhibitors; Aged; Animals; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Decision-Making; DNA Mutational Analysis; Dutasteride; Finasteride; Homeodomain Proteins; Humans; Male; Mice, Knockout; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Staging; Patient Selection; Precision Medicine; Predictive Value of Tests; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Retrospective Studies; Time Factors; Transcription Factors; Treatment Outcome | 2017 |
A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia.
Topics: Biopsy; Enzyme Inhibitors; Expert Testimony; Finasteride; Hispanic or Latino; Humans; Male; Middle Aged; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Surgery, Computer-Assisted; Ultrasonography | 2008 |
[Histopathology reports of findings of prostate needle biopsies. Individual treatment].
Topics: Adenocarcinoma; Attitude of Health Personnel; Biomarkers, Tumor; Biopsy, Needle; Cell Proliferation; Cooperative Behavior; Decision Support Techniques; Disease Progression; Finasteride; Germany; Guideline Adherence; Humans; Interdisciplinary Communication; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Palliative Care; Patient Care Planning; Phosphodiesterase 5 Inhibitors; Precision Medicine; Prognosis; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Surveys and Questionnaires | 2013 |
Prevention of prostate cancer with finasteride.
Topics: 5-alpha Reductase Inhibitors; Biopsy; Enzyme Inhibitors; Finasteride; Humans; Male; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk; Testosterone | 2003 |
Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Animals, Genetically Modified; Antigens, Viral, Tumor; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Flutamide; Male; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Testosterone | 2007 |
[The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].
Topics: 5-alpha Reductase Inhibitors; Aged; Biomarkers, Tumor; Biopsy; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors | 2007 |
Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (finasteride). A methodologic approach.
Topics: 5-alpha Reductase Inhibitors; Aged; Bayes Theorem; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 1996 |
Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective.
Topics: Enzyme Inhibitors; Finasteride; Humans; Male; Precancerous Conditions; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors | 2001 |